Alstrom syndrome screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Alstrom syndrome}} | {{Alstrom syndrome}} | ||
{{CMG}}, {{AE}} {{AN}}; {{RT}} | {{CMG}}, {{AE}} {{AN}}; {{RT}} | ||
==Screening== | ==Screening== | ||
| Line 18: | Line 16: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs | [[Category:Needs overview]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 14:36, 25 February 2013
|
Alstrom syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Alstrom syndrome screening On the Web |
|
American Roentgen Ray Society Images of Alstrom syndrome screening |
|
Risk calculators and risk factors for Alstrom syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Screening
- Fasting glucose levels are evaluated every two to three months. Closer follow-up is needed if fasting or postprandial blood glucose concentrations are elevated.
- Urinalysis and plasma concentrations of electrolytes, uric acid, BUN, and creatinine should be estimated twice-yearly.
- Annual assessment of vision and hearing; weight, height, and body mass index; heart (including echocardiography); plasma insulin concentration; lipid profile; plasma ALT, AST, and GGT concentrations; pulmonary function; thyroid function.
- Renal and bladder ultrasound examinations should be conducted if symptomatic and/or if urinalysis is abnormal, every one to two years.